MarginsXMarginsX
Home › Markets › Health Care › CALC

CalciMedica Inc. (CALC)

CALC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.19
-1.65% on the day
Market cap
$8.2M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerCALC on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2023
SEC CIK0001534133
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
3.0 months
$4.6M cash at September 30, 2026
Share count, 1 year
See the dilution note
+506.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$199K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result, there is substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-10
Cash and burn$4.6M cash; operating cash flow -$4.5M a quarter.Report 2026-09-30
Shares outstanding6,895,149 (2026-11-05); 5,684,873 three years earlier. 3y figure adjusted for split (1-for-5 overall).Cover page 2026-11-05
Reverse splits, 3 years1; latest 1-for-5 on 2026-08-31Source 2026-08-31
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-09-30
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-03-18
AuditorBaker Tilly US, LLP, San Diego, California, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $199K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
Not filed-$1.7M-$3.9M$4.6MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q2 2026
2026-06-30
Not filed-$7.7M-$4.6M$18.6MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q1 2026
2026-03-31
Not filed$5.0M-$4.9M$8.2MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q4 2025
2025-12-31
Not filed-$10.8M-$4.9M$11.5MNo debt tagsNeeds four quarters10-K 2026-03-03
Q3 2025
2025-09-30
Not filed-$7.8M-$4.8M$5.5MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q2 2025
2025-06-30
Not filed-$6.0M-$6.7M$5.9MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q1 2025
2025-03-31
Not filed-$5.0M-$4.9M$12.6MNo debt tagsNeeds four quarters10-Q 2026-11-10
Q4 2024
2024-12-31
Not filed-$4.3M-$5.0M$7.9MNo debt tagsNeeds four quarters10-K 2026-03-03

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-30
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-10
Latest proxyDEF 14A2026-07-23

Source: SEC EDGAR submissions feed, 537 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-11.0%
1 month+8.0%
3 months-63.2%
Year to date-96.3%
1 year-92.5%
From 52-week high-96.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
MTVAMetaVia Inc.$1.21-7.31%$8.1M
RKTORocket One Inc.$0.3210+0.03%$8.0M
ENSCEnsysce Biosciences Inc.$0.4095-2.13%$8.0M
VTGNVistagen Therapeutics Inc.$0.1843+2.11%$8.5M
MBRXMoleculin Biotech Inc.$7.14-9.28%$7.6M
PHIOPhio Pharmaceuticals Corp.$0.7522-2.44%$9.0M
BFRGBullfrog AI Holdings Inc.$0.4878-9.92%$9.0M
UPCUniverse Pharmaceuticals Inc.$1.48-1.99%$7.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier